FDA 483 - Aura Cacia - December 01, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Aura Cacia, an OTC drug manufacturer in Urbana, IA, was cited with five observations during an FDA inspection from November 27 to December 1, 2023. The firm exhibited significant deficiencies in its quality control systems, including inadequate component testing, lack of written production and process control procedures, and insufficient stability data to support product expiration dates. These issues indicate a systemic failure to ensure the identity, strength, purity, and quality of its OTC hand sanitizer products.
ID · a44c4868-25f6-49a4-a608-d99411c72ee8